Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Volume 37 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang. Peripheral CD4+CD8+ double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus[J]. The Journal of Biomedical Research, 2023, 37(1): 59-68. doi: 10.7555/JBR.36.20220094
Citation: Kai Chang, Wanlin Na, Chenxia Liu, Hongxuan Xu, Yuan Liu, Yanyan Wang, Zhongyong Jiang. Peripheral CD4+CD8+ double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus[J]. The Journal of Biomedical Research, 2023, 37(1): 59-68. doi: 10.7555/JBR.36.20220094

Peripheral CD4+CD8+ double positive T cells: A potential marker to evaluate renal impairment susceptibility during systemic lupus erythematosus

doi: 10.7555/JBR.36.20220094
More Information
  • Corresponding author: Yanyan Wang and Zhongyong Jiang, Division of Cellular and Molecular Diagnostics, Department of Medical Laboratory, The General Hospital of Western Theater Command, 270 Rong Du Avenue, Jinniu District, Chengdu, Sichuan 610083, China. E-mails: wangyanyanmail@126.com and jiangzhongyongmail@126.com
  • Received: 2022-04-27
  • Revised: 2022-07-31
  • Accepted: 2022-08-04
  • Published: 2022-09-28
  • Issue Date: 2023-01-28
  • Lupus nephritis (LN) has a high incidence in systemic lupus erythematosus (SLE) patients, but there is a lack of sensitive predictive markers. The purpose of the study was to investigate the association between the CD4+CD8+ double positive T (DPT) lymphocytes and LN. The study included patients with SLE without renal impairment (SLE-NRI), LN, nephritic syndrome (NS), or nephritis. Peripheral blood lymphocyte subsets were analyzed by flow cytometry. Biochemical measurements were performed with peripheral blood in accordance with the recommendations proposed by the National Center for Clinical Laboratories. The proportions of DPT cells in the LN group were significantly higher than that in the SLE-NRI group (t=4.012, P<0.001), NS group (t=3.240, P=0.001), and nephritis group (t=2.57, P=0.011). In the LN group, the risk of renal impairment increased significantly in a DPT cells proportion-dependent manner. The risk of LN was 5.136 times (95% confidence interval, 2.115–12.473) higher in cases with a high proportion of DPT cells than those whose proportion of DPT cells within the normal range. These findings indicated that the proportion of DPT cells could be a potential marker to evaluate LN susceptibility, and the interference of NS and nephritis could be effectively excluded when assessing the risk of renal impairment during SLE with DPT cell proportion.


  • CLC number: R593.242, Document code: A
    The authors reported no conflict of interests.
  • loading
  • [1]
    Yu F, Haas M, Glassock R, et al. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes[J]. Nat Rev Nephrol, 2017, 13(8): 483–495. doi: 10.1038/nrneph.2017.85
    Delarche A, Lumbroso C, Fournier A, et al. Incidence and outcome of lupus nephritis in French Polynesia[J]. Clin Nephrol, 2018, 89: 41–49. doi: 10.5414/CN109194
    Feng X, Pan W, Liu L, et al. Prognosis for hospitalized patients with systemic lupus erythematosus in China: 5-year update of the Jiangsu cohort[J]. PLoS One, 2016, 11(12): e0168619. doi: 10.1371/journal.pone.0168619
    Wang S, Shen H, Bai B, et al. Increased CD4+CD8+ double-positive T Cell in patients with primary Sjögren's syndrome correlated with disease activity[J]. J Immunol Res, 2021, 6658324. doi: 10.1155/2021/6658324
    Marrero YT, Suárez VM, Abraham CMM, et al. Immunophenotypic characterization of double positive T lymphocytes in Cuban older adults[J]. Exp Gerontol, 2021, 152: 111450. doi: 10.1016/j.exger.2021.111450
    Rahemtullah A, Harris NL, Dorn ME, et al. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma[J]. Leuk Lymphoma, 2008, 49(10): 1870–1878. doi: 10.1080/10428190802308728
    Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Arthritis Rheumatol, 2019, 71(9): 1400–1412. doi: 10.1002/art.40930
    Fanouriakis A, Tziolos N, Bertsias G, et al. Update οn the diagnosis and management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2021, 80(1): 14–25. doi: 10.1136/annrheumdis-2020-218272
    Jiang Z, Liu X, Chang K, et al. Allyl isothiocyanate inhibits the proliferation of renal carcinoma cell line GRC-1 by inducing an imbalance between Bcl2 and Bax[J]. Med Sci Monit, 2016, 22: 4283–4288. doi: 10.12659/MSM.897315
    Chang K, Jiang Z, Liu C, et al. The effects of CYP2C19 genotype on the susceptibility for nephrosis in cardio-cerebral vascular disease treated by anticoagulation[J]. Medicine, 2016, 95(38): e4954. doi: 10.1097/MD.0000000000004954
    Liu S, Gong Y, Ren H, et al. The prevalence, subtypes and associated factors of hyperuricemia in lupus nephritis patients at chronic kidney disease stages 1–3[J]. Oncotarget, 2017, 8(34): 57099–57108. doi: 10.18632/oncotarget.19051
    Ameh OI, Kengne AP, Jayne D, et al. Standard of treatment and outcomes of adults with lupus nephritis in Africa: a systematic review[J]. Lupus, 2016, 25(11): 1269–1277. doi: 10.1177/0961203316640915
    Pahar B, Lackner AA, Veazey RS. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines[J]. Eur J Immunol, 2006, 36(3): 583–592. doi: 10.1002/eji.200535520
    Parel Y, Chizzolini C. CD4+ CD8+ double positive (DP) T cells in health and disease[J]. Autoimmun Rev, 2004, 3(3): 215–220. doi: 10.1016/j.autrev.2003.09.001
    Dashtsoodol N, Shigeura T, Aihara M, et al. Alternative pathway for the development of Vα14+ NKT cells directly from CD4-CD8- thymocytes that bypasses the CD4+CD8+ stage[J]. Nat Immunol, 2017, 18(3): 274–282. doi: 10.1038/ni.3668
    Schäfer S, Zernecke A. CD8+ T cells in atherosclerosis[J]. Cells, 2020, 10(1): 37. doi: 10.3390/cells10010037
    Abd El-Kader SM, Al-Shreef FM. Inflammatory cytokines and immune system modulation by aerobic versus resisted exercise training for elderly[J]. Afr Health Sci, 2018, 18(1): 120–131. doi: 10.4314/ahs.v18i1.16
    Wu Z, Zheng Y, Sheng J, et al. CD3+CD4-CD8- (double-negative) T cells in inflammation, immune disorders and cancer[J]. Front Immunol, 2022, 13: 816005. doi: 10.3389/fimmu.2022.816005
    Glatzová D, Cebecauer M. Dual role of CD4 in peripheral T lymphocytes[J]. Front Immunol, 2019, 10: 618. doi: 10.3389/fimmu.2019.00618
    Pérez-Antón E, Egui A, Thomas MC, et al. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients[J]. PLoS Negl Trop Dis, 2018, 12(5): e0006480. doi: 10.1371/journal.pntd.0006480
    Wu Y, Cai B, Feng W, et al. Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus[J]. Indian J Med Res, 2014, 140(4): 513–519. https://pubmed.ncbi.nlm.nih.gov/25488445/
    Frahm MA, Picking RA, Kuruc JD, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection[J]. J Immunol, 2012, 188(9): 4289–4296. doi: 10.4049/jimmunol.1103701
    Choe JY, Lee SS, Kwak SG, et al. Anti-Sm antibody, damage index, and corticosteroid use are associated with cardiac involvement in systemic lupus erythematosus: data from a prospective registry study[J]. J Korean Med Sci, 2020, 35(21): e139. doi: 10.3346/jkms.2020.35.e139
    Ahn SS, Jung SM, Yoo J, et al. Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus[J]. Rheumatol Int, 2019, 39(11): 1937–1944. doi: 10.1007/s00296-019-04445-y
    Wang X, Xia Y. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies[J]. Front Immunol, 2019, 10: 1667. doi: 10.3389/fimmu.2019.01667
    Rekvig OP. Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks[J]. Clin Exp Immunol, 2015, 179(1): 5–10. doi: 10.1111/cei.12296
  • 加载中


    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(4)

    Article Metrics

    Article views (771) PDF downloads(103) Cited by()
    Proportional views
    Relative Articles


    DownLoad:  Full-Size Img  PowerPoint